Cure8 research brief
The study points to three bile-acid–related genes that may be linked to inflammation in ulcerative colitis and could serve as biomarkers or targets for future research into disease mechanisms and patient stratification.
Researchers studying IBD biology or biomarkers, clinicians interested in emerging UC markers, and patients who follow translational research developments.
The study combined public UC transcriptome datasets, multiple machine-learning algorithms, and single-cell analyses to nominate three bile-acid metabolism–associated genes (BAMGs). The authors then tested those genes in a mouse colitis model (DSS) and measured expression in peripheral blood cells from UC patients using RT-qPCR.
Experimental results in mouse colon tissue and patient blood supported the computational findings: CH25H was increased while SLC23A1 and PHYH were decreased.
The paper links these genes to differences in immune-cell populations (naïve B cells, neutrophils, monocytes, CD8 T cells, macrophages) and shows variable expression across T- and B-cell subsets by single-cell analysis.
The authors present these genes as candidate biomarkers and possible contributors to UC pathogenesis, but the work is exploratory and based on retrospective datasets plus initial experimental validation.
Results are based on integration of public transcriptomic datasets, machine-learning selection, mouse-model validation, and limited patient blood testing; further validation in larger, independent clinical cohorts is needed.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Researchers used genetics plus single-cell sequencing and ELISA to prioritize plasma protein ratios that may causally relate to ulcerative colitis. If validated in larger studies, such biomarkers could help with...
If fecal GP2 reliably reflects UC activity and microbial changes, it could become a noninvasive marker to track inflammation or to study disease mechanisms that differ between UC and CD.
Researchers used genetics, microbiome, metabolism, and immune profiling together to nominate biological pathways and a four-gene signature that might help diagnose or explain ulcerative colitis. If validated later, these...
